Philip Noel Newsome (Philip N Newsome, P N Newsome, Phillip N Newsome, Philip Newsome)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 42

Top Topics

Insulin Resistance

Systematic Review

Top Venues

Hepatology (Baltimore, Md.)

The New England journal of medicine

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Gideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, Yung-Yi Chen, Richard Fox, Anna Rowe, Jessica Douglas-Pugh, Douglas Thorburn, Eleanor Barnes, Guruprasad P Aithal, Diana Hull, Khushpreet Bhandal, Kathryn Olsen, Paul Woodward, Siân Lax, Philip Noel Newsome, David J Smith, Antero Kallio, David H Adams, Victoria Homer, Christopher J Weston
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial. Hepatology communications 8 (5) (2024)
Julian G Yeh, Philip Noel Newsome
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study. Hepatology (Baltimore, Md.) (2024)
Julian G Yeh, Philip Noel Newsome
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study. Hepatology (Baltimore, Md.) 79 (6) (2024)
A Sidney Barritt, Feng Yu, Andrea R Mospan, Philip Noel Newsome, Michael Roden, Heather Lynne Morris, Stephen Caldwell, Brent A Neuschwander-Tetri, null null
High concordance between nonalcoholic fatty liver disease and metabolic dysfunction associated steatotic liver disease in the TARGET-NASH real world cohort. The American journal of gastroenterology (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
A Sidney Barritt, Feng Yu, Andrea R Mospan, Philip Noel Newsome, Michael Roden, Heather Lynne Morris, Stephen Caldwell, Brent A Neuschwander-Tetri, null null
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort. The American journal of gastroenterology 119 (8) (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Xiao-Dong Zhou, Seung-Up Kim, Terry Cheuk Fung Yip, Salvatore Petta, Atsushi Nakajima, Emmanuel Tsochatzis, Jérôme Boursier, Elisabetta Bugianesi, Hannes Hagström, Wah-Kheong Chan, Manuel Romero, Jose Luis Calleja, Victor de Lédinghen, Laurent Castéra, Arun J Sanyal, George Boon-Bee Goh, Philip Noel Newsome, Jiangao Fan, Michelle Lai, Céline Fournier-Poizat, Hye-Won Lee, Grace Lai-Hung Wong, Angelo Armandi, Ying Shang, Grazia Pennisi, Elba Llop, Masato Yoneda, Marc de Saint-Loup, Clémence M Canivet, Carmen Lara-Romero, Rocio Gallego-Duràn, Amon Asgharpour, Kevin Kim-Jun Teh, Sara Mahgoub, Mandy Sau-Wai Chan, Huapeng Lin, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Ming-Hua Zheng, null null
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease. Gut (2024)
A Sidney Barritt, Feng Yu, Andrea R Mospan, Philip Noel Newsome, Michael Roden, Heather Lynne Morris, Stephen Caldwell, Brent A Neuschwander-Tetri, null null
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort. The American journal of gastroenterology (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine 391 (4) (2024)
Gideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, Yung-Yi Chen, Richard Fox, Anna Rowe, Jessica Douglas-Pugh, Douglas Thorburn, Eleanor Barnes, Guruprasad P Aithal, Diana Hull, Khushpreet Bhandal, Kathryn Olsen, Paul Woodward, Siân Lax, Philip Noel Newsome, David J Smith, Antero Kallio, David H Adams, Victoria Homer, Christopher J Weston
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trial. Hepatology communications 8 (5) (2024)
Arun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, Guy W Neff, Eric Lawitz, Elisabetta Bugianesi, Quentin M Anstee, Samina Ajaz Hussain, Philip Noel Newsome, Vlad Ratziu, Azadeh Hosseini-Tabatabaei, Jörn Markus Schattenberg, Mazen Noureddin, Rohit L Loomba, Ramy Younes, null null
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis. The New England journal of medicine 391 (4) (2024)
Philip Noel Newsome, Arun J Sanyal, Guy Neff, Jörn Markus Schattenberg, Vlad Ratziu, Judith Ertle, Jasmin Link, Alison Mackie, Corinna Schoelch, Eric Lawitz, null null
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis. Nature communications 14 (1) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Neeraj Bhala, James W Ferguson, Neil Rajoriya, Philip Noel Newsome
Using global burden of hepatocellular cancer and liver cirrhosis as a driver to tackle preventable mortality and morbidity nationally and regionally. Hepatology (Baltimore, Md.) 77 (4) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition'†. Hepatology (Baltimore, Md.) (2023)
Neeraj Bhala, James W Ferguson, Neil Rajoriya, Philip Noel Newsome
Using global burden of hepatocellular cancer and liver cirrhosis as a driver to tackle preventable mortality and morbidity nationally and regionally. Hepatology (Baltimore, Md.) 77 (4) (2023)
Federico Ravaioli, Elton Dajti, Alessandro Mantovani, Philip Noel Newsome, Giovanni Targher, Antonio Colecchia
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis. Gut (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Jérôme Boursier, Marine Roux, Charlotte Costentin, Julien Chaigneau, Céline Fournier-Poizat, Aldo Trylesinski, Clémence M Canivet, Sophie Michalak, Brigitte Le Bail, Valérie Paradis, Pierre Bedossa, Nathalie Sturm, Victor de Ledinghen, null null, null null, Philip Noel Newsome
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests. Nature communications 14 (1) (2023)
Neeraj Bhala, James W Ferguson, Neil Rajoriya, Philip Noel Newsome
Using global burden of hepatocellular cancer and liver cirrhosis as a driver to tackle preventable mortality and morbidity nationally and regionally. Hepatology (Baltimore, Md.) 77 (4) (2023)
Ameeta Retzer, Bircan Ciytak, Foram Khatsuria, Juma El-Awaisi, Isobel Marion Harris, Laura Chapman, Tony Kelly, Jenny Richards, Emily Lam, Philip Noel Newsome, Melanie Jane Calvert, null null
A toolkit for capturing a representative and equitable sample in health research. Nature medicine 29 (12) (2023)
Mary E Rinella, Graciela E Castro Narro, Aleksander Krag, Norah A Terrault, Philip Noel Newsome
Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Ferenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, Arjun Narayan Ajmer Jayaswal, Michael Trauner, Jérôme Boursier, Céline Fournier, Katharina Staufer, Rudolf E Stauber, Elisabetta Bugianesi, Ramy Youne, Silvia Gaia, Monica Lupșor-Platon, Salvatore Petta, Toshihide Shima, Takeshi Okanoue, Sanjiv Mahadeva, Wah-Kheong Chan, Peter J Eddowes, Gideon M Hirschfield, Philip Noel Newsome, Vincent Wai-Sun Wong, Victor de Ledinghen, Jiangao Fan, Feng Shen, Jeremy F Cobbold, Yoshio Sumida, Akira Okajima, Jörn M Schattenberg, Christian Labenz, Won Kim, Myoung Seok Lee, Johannes Wiegand, Thomas Karlas, Yusuf Yilmaz, Guruprasad Padur Aithal, Naaventhan Palaniyappan, Christophe Cassinotto, Sandeep Aggarwal, Harshit Garg, Geraldine J Ooi, Hirokazu Takahashi, Masato Yoneda, Marianne Ziol, Nathalie Barget, Andreas Geier, Theresa Tuthill, M Julia Brosnan, Quentin Mark Anstee, Stefan Neubauer, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides, null null
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut (2021)
Pere Ginès, Laurent Castera, Frank Lammert, Isabel Graupera, Miquel Serra-Burriel, Alina M Allen, Vincent Wai-Sun Wong, Phillipp Hartmann, Maja Thiele, Llorenç Caballeria, Robert J de Knegt, Ivica Grgurevic, Salvador Augustin, Emmanuel A Tsochatzis, Jörn Markus Schattenberg, Indra Neil Guha, Andrea Martini, Rosa M Morillas, Montserrat Garcia-Retortillo, Harry de Koning, Núria Fabrellas Padrés, Judit Pich, Ann T Ma, M Alba Diaz, Dominique Roulot, Philip Noel Newsome, Michael Manns, Patrick S Kamath, Aleksander Krag, null null
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology (Baltimore, Md.) (2021)
Hannes Hagström, Leon A Adams, Alina M Allen, Christopher D Byrne, Yoosoo Chang, Henning Grønbæk, Mona Ismail, Peter Jepsen, Fasiha Kanwal, Jennifer R Kramer, Jeffrey Victor Lazarus, Michelle T Long, Rohit Loomba, Philip Noel Newsome, Denis Moir, Seungho Ryu, Jörn Markus Schattenberg, Marina Serper, Nick Sheron, Tracey G Simon, Elliot B Tapper, Sarah Wild, Vincent Wai-Sun Wong, Yusuf Yilmaz, Shira Zelber-Sagi, Fredrik O Åberg
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. Hepatology (Baltimore, Md.) 74 (1) (2021)
Karen Macpherson, Olalekan Lee Aiyegbusi, Lauren Elston, Susan Myles, Jennifer Washington, Nisha Sungum, Mark Briggs, Philip Noel Newsome, Melanie Jane Calvert
A scoping review of patient and public perspectives on cell and gene therapies. Regenerative medicine 16 (11) (2021)
Alice Morgan, Sally Hartmanis, Emmanuel A Tsochatzis, Philip Noel Newsome, Stephen D Ryder, Rachel Elliott, Lefteris Floros, Richard Hall, Victoria Higgins, George Stanley, Sandrine Cure, Sharad Vasudevan, Lynne Pezzullo
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018. The European journal of health economics : HEPAC : health economics in prevention and care 22 (4) (2021)
Paul Horn, Philip Noel Newsome
Commentary: advances in the pharmacotherapy of NASH-anti-diabetic drugs and beyond. Alimentary pharmacology & therapeutics 51 (1) (2020)
Alexander Boyd, Philip Noel Newsome
Editorial: early and late mortality following unscheduled admissions for severe liver disease across England and Wales. Alimentary pharmacology & therapeutics 49 (10) (2020)
Lozan Sheriff, Reenam S Khan, Raquel Saborano, Richard Wilkin, Nguyet-Thin Luu, Ulrich L Gunther, Stefan G Hubscher, Philip Noel Newsome, Patricia F Lalor
Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than Nrf2 -/- animals. Disease models & mechanisms 13 (12) (2020)
Roberta Angioni, Bianca Calì, Vasanthy Vigneswara, Marika Crescenzi, Ana Merino, Ricardo Sánchez-Rodríguez, Cristina Liboni, Martin J Hoogduijn, Philip Noel Newsome, Maurizio Muraca, Francesco Paolo Russo, Antonella Viola
Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice. International journal of molecular sciences 21 (22) (2020)
Paul Horn, Philip Noel Newsome
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Alimentary pharmacology & therapeutics 51 (10) (2020)
Philip Noel Newsome, Sven Francque, Stephen Harrison, Vlad Ratziu, Luc Van Gaal, Salvatore Calanna, Morten Hansen, Martin Linder, Arun J Sanyal
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. Alimentary pharmacology & therapeutics 50 (2) (2019)
Reenam S Khan, Fernando Bril, Kenneth Cusi, Philip Noel Newsome
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.) 70 (2) (2019)
Sarah A Townsend, R G Edgar, Paul Ellis, D Kantas, Philip Noel Newsome, A M Turner
Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease. Alimentary pharmacology & therapeutics 47 (7) (2018)
Philip Noel Newsome, Rob Cramb, Suzanne M Davison, John F Dillon, Mark Foulerton, Edmund M Godfrey, Richard Hall, Ulrike Harrower, Mark Hudson, Andrew Langford, Anne Mackie, Robert Mitchell-Thain, Karen Sennett, Nicholas C Sheron, Julia Verne, Martine Walmsley, Andrew Yeoman
Guidelines on the management of abnormal liver blood tests. Gut 67 (1) (2017)
Peter J Eddowes, N McDonald, N Davies, S I K Semple, T J Kendall, J Hodson, Philip Noel Newsome, R B Flintham, R Wesolowski, L Blake, R V Duarte, C J Kelly, A H Herlihy, M D Kelly, S P Olliff, S G Hübscher, Jonathan Andrew Fallowfield, Gideon M Hirschfield
Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 47 (5) (2017)